Emerging Innovations Row

2023 Emerging Innovations Row

Cost: $1,750 (Industry)

Emerging Innovations Row is an exciting opportunity at this year’s annual scientific meeting for companies early in development of diagnostics and therapies to the heart failure space. We believe this will be an important opportunity for emerging technology companies looking to:

  • Introduce your approach to physicians and identify potential FIH or other clinical trial sites
  • Obtain market research/input from many experienced HF providers in terms of clinical trial or device design
  • Get exposure to both small and large medical device companies for the purpose of potential investment and/or strategic partnership

Emerging Innovations Row provides companies the opportunity to share information about their emerging products. Located in a designated focus area in the Exhibit Hall, each participating company will be provided with a small table-top exhibit area to showcase their diagnostic or therapy.

Tables may be staffed at any time during regular Exhibit Hall hours to answer questions. Emerging Innovations Row exhibitors will ONLY have access to the HFSA exhibit hall during hall hours. Access to the HFSA Educational Sessions is not included in the Emerging Innovations Row registration. Individuals interested in participating in the full conference can find registration information on the 2023 HFSA Annual Scientific Meeting website.

Application Criteria

  1. Emerging Innovations Row is not intended for companies already performing a pivotal clinical trial for regulatory approval or have been in business for more than three years.
  2. Physicians with a bench prototype of a device are also eligible to apply for this opportunity.
  3. Companies / physicians are only eligible to apply for this category once. HFSA encourages continued engagement in the form of a 10×10 booth and/or corporate membership.

Examples of information that could be included at the exhibitor table:

  • Model or demonstration of your diagnostic or device
  • Videos to explain how diagnostic or device works
  • Company brochures
  • Other product information
  • Clinical trial outlines
  • Market research questionnaires


  • All Emerging Innovations Row applications received by the deadline will be listed in the Annual Scientific Meeting Digital Program Book.
  • Emerging Innovations Row information will be included in email announcements to pre-registrants regarding exhibit hall activities.
  • All Emerging Innovations Row companies will be provided a small table-top exhibit in the Exhibit Hall

All other rules for exhibiting apply. Payment must be received with the application.  Invoicing is not an option for this category. Submissions must be received by September 1, 2023, in order to be included in the 2023 HFSA Annual Scientific Meeting Digital Program and posted on the exhibit hall floor plan.

Please contact HFSA Conference Organizer Lindsey Best with any logistical questions or HFSA’s Director of Development Michelle Poinelli at mpoinelli@hfsa.org to find out more about HFSA Corporate Membership.

Content last updated on April 4th, 2023 at 01:17 pm